Neurometabolic Disorders 1
The Neurometabolic Disorders 1 session will be discussing CNS cofactor deficiencies (riboflavin, folate), neurotransmitter disorders.
This educational activity is supported by an educational grant from Ultragenyx.
- Describe phenotypes and identify biochemical findings of disorders of creatinebiosynthesis and transport.
- List categories of phenotypes associated with purine disorders and biochemical profiles associated with individual disorders.
- Summarize categories of phenotypes associated with pyrimidine disorders and biochemical profiles associated with individual disorders.
Reid Sutton, MD
Reid Sutton, MD, speaker for this session, is a site principle investigator for Ultragenyx and an advisory board member for Applied Therapeutics and Aceragen Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance